Creative Medical Technology Holdings, Inc. Long-Term Debt, Maturity, Year Two
Creative Medical Technology Holdings, Inc. (CELZ) had Long-Term Debt, Maturity, Year Two of $168.30 thousand as of 2020-03-31, per its 10-Q filed 2020-05-15.
Discontinued › Notes › Commitment and Contingencies › Long-Term Debt, Fiscal Year Maturity › Long-Term Debt, Maturity, Year Two and Three
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo · last filed 2020-05-15
- 2020-03-31: Long-Term Debt, Maturity, Year Two $168.30K.
- 2019-09-30: Long-Term Debt, Maturity, Year Two $1.03M.
- 2019-06-30: Long-Term Debt, Maturity, Year Two $1.01M.
- 2019-03-31: Long-Term Debt, Maturity, Year Two $972.10K.
| Period end | Long-Term Debt, Maturity, Year Two |
|---|---|
| 2020-03-31 | $168.30K 10-Q · filed 2020-05-15 |
| 2019-09-30 | $1.03M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.01M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $972.10K 10-Q · filed 2019-05-20 |
| 2018-09-30 | $987.75K 10-Q · filed 2018-11-14 |
| 2018-06-30 | $554.66K 10-Q · filed 2018-08-14 |
| 2018-03-31 | $262.50K 10-Q · filed 2018-08-03 |
| 2017-12-31 | $0.00 10-K · filed 2018-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |